- Report
- September 2025
- 141 Pages
Global
From €2249EUR$2,549USD£1,969GBP
€2646EUR$2,999USD£2,317GBP
- Report
- August 2025
- 136 Pages
Global
From €2249EUR$2,549USD£1,969GBP
€2646EUR$2,999USD£2,317GBP
- Report
- August 2025
- 124 Pages
Global
From €2249EUR$2,549USD£1,969GBP
€2646EUR$2,999USD£2,317GBP
- Report
- January 2025
- 131 Pages
Global
From €2249EUR$2,549USD£1,969GBP
€2646EUR$2,999USD£2,317GBP
- Report
- October 2025
- 140 Pages
Global
From €5249EUR$5,950USD£4,597GBP
- Report
- June 2025
- 150 Pages
Global
From €5249EUR$5,950USD£4,597GBP
- Report
- May 2025
- 120 Pages
Global
From €5249EUR$5,950USD£4,597GBP
- Report
- January 2025
- 170 Pages
Global
From €5249EUR$5,950USD£4,597GBP
- Report
- November 2025
- 199 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- March 2025
- 200 Pages
Global
From €2197EUR$2,490USD£1,924GBP
- Report
- May 2025
- 200 Pages
Global
From €2197EUR$2,490USD£1,924GBP
- Report
- February 2025
- 120 Pages
Global
From €2197EUR$2,490USD£1,924GBP
- Report
- February 2025
- 120 Pages
Global
From €2197EUR$2,490USD£1,924GBP
- Report
- December 2025
- 374 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- December 2025
- 177 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- March 2025
- 200 Pages
Global
From €3961EUR$4,490USD£3,469GBP
- Report
- November 2025
- 196 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- November 2025
- 194 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- November 2025
- 190 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- November 2025
- 185 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more